Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRET: Mass Azithromycin for Trachoma Elimination
NCT00792922Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- May 2008
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of azithromycin in trachoma, sponsored by Johns Hopkins University. Primary endpoint: Community Prevalence of Trachoma at 36 months. Started May 2008; status: completed.
02
Drugs
azithromycin
03
Conditions
trachoma
Beyond the preview
Go deeper on NCT00792922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792922.